SCHEMBL8202004

SCHEMBL8202004

N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O.O=C(O)[C@@H]1CC(=S)CN1C(=O)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.45
FAP Q12884 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
DPP9 Q86TI2 1/20 0.45
DPP7 Q9UHL4 1/20 0.45
YAP1 P46937 1/20 0.43
FAAH O00519 1/20 0.42
LTA4H P09960 6/20 0.42
LAP3 P28838 1/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
PLA2G2A P14555 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42
ACE P12821 1/20 0.42
ALPI P09923 1/20 0.41
PKM P14618 1/20 0.41
PTGS1 P23219 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6930978 0.93 LTA4H (0.46) DPP4FAPDPP8DPP9DPP7
SCHEMBL7905108 0.92 GPR132 (0.43) DPP4FAPDPP8DPP9DPP7
SCHEMBL6935180 0.91 DPP4 (0.47) DPP4FAPDPP8DPP9DPP7
SCHEMBL6930651 0.90 AGTR2 (0.43) DPP4FAPDPP8DPP9DPP7
SCHEMBL6935321 0.89 DPP4 (0.45) DPP4FAPDPP8DPP9DPP7
SCHEMBL6935894 0.86 YAP1 (0.48) DPP4FAPDPP8DPP9DPP7
SCHEMBL6933977 0.86 LTA4H (0.48) DPP4FAPDPP8DPP9DPP7
SCHEMBL6934215 0.85 DPP4 (0.42) DPP4FAPDPP8DPP9DPP7
SCHEMBL7908667 0.85 DPP4 (0.44) DPP4FAPDPP8DPP9DPP7
SCHEMBL7896696 0.83 RAB9A (0.44) DPP4FAPDPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6093696-A N-ACETYL-D-THIOPROLINE-(O-2,6-DICHLOROBENZYL)-L-TYROSINE, FOR EXAMPLE; SELECTIVELY INHIBIT THE ALPHA 4 SUBGROUP OF INTEGRINS FROM BINDING TO THEIR LIGANDS; USE IN PROPHYLAXIS OR TREATMENT OF IMMUNE OR INFLAMMATORY DISEASES CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 US disclosed